Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma

Oncology Reports

Volumn 8, Issue 1, 2001, Pages 115-118

  Reinhold, Uwe ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Circulating tumor cells; Malignant melanoma; Plasma; Serum; Tyrosinase

Indexed keywords

MART1 ANTIGEN; MELANOCYTE LINEAGE SPECIFIC ANTIGEN GP100; MELANOCYTE LINEAGE-SPECIFIC ANTIGEN GP100; MEMBRANE PROTEIN; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; PORPHOBILINOGEN DEAMINASE; RNA; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BLOOD; BLOOD CELL; CHEMISTRY; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; MALE; MELANOMA; METASTASIS; MIDDLE AGED; PATHOLOGY; PLASMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR EMBOLISM;

ADULT; AGED; ANTIGENS, NEOPLASM; BLOOD CELLS; FEMALE; HUMANS; HYDROXYMETHYLBILANE SYNTHASE; MALE; MELANOMA; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PLASMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 0035233902     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Hoon DS, Bostick P, Kuo C, Okamoto T, Wang HJ, Elashoff R and Morton DL: Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. Cancer Res 60: 2253-2257, 2000.
2. Brossait P, Keilholz U, Willhauck M, Scheibenbogen C, Mohler T and Hunstein W: Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol 101: 887-889, 1993.